🔎 Trials Near Me

Hjem › Prostatakreft › Connecticut › New Haven

Kliniske studier for Prostatakreft i New Haven, CT

20 studier for Prostatakreft søker deltakere på steder i og rundt New Haven (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • Yale Cancer Center, New Haven
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RekruttererFase 2
  • Yale Cancer Center, New Haven
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

RekruttererFase 1/2
  • Yale University, New Haven
Alder 18 og eldre · Menn · Oppdatert 25. sep. 2026 · NCT06800313

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

RekruttererFase 3
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06136650

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

RekruttererFase 1/2
  • GSK Investigational Site, New Haven
Alder 18 og eldre · Menn · Oppdatert 18. sep. 2026 · NCT06990880

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

RekruttererFase 2
  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3 mi unna
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT05011383

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

RekruttererFase 3
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
  • Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven · 3 mi unna
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT06925737

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

RekruttererFase 2
  • Yale Cancer Center, New Haven
Alder 18 og eldre · Menn · Oppdatert 14. sep. 2026 · NCT06111781

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

RekruttererFase 1
  • Yale Cancer Center, New Haven
Alder 18 og eldre · Menn · Oppdatert 8. sep. 2026 · NCT05800665

A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth

RekruttererObservasjonsstudie
  • Wren Laboratories, Branford · 6 mi unna
Alder 45 til 80 · Menn · Oppdatert 21. aug. 2026 · NCT07454603

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

RekruttererFase 1
  • Yale New Haven Hospital, New Haven
Alder 18 og eldre · Menn · Oppdatert 21. aug. 2026 · NCT04221542

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

RekruttererFase 2
  • New Haven Hospital - Yale Cancer Center, New Haven
Alder 18 og eldre · Menn · Oppdatert 17. aug. 2026 · NCT06842498

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Yale University School of Medicine, New Haven
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

RekruttererFase 1
  • Yale New Haven Hospital, New Haven
Alder 18 til 100 · Menn · Oppdatert 13. aug. 2026 · NCT05519449

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

RekruttererFase 3
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi unna
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

RekruttererFase 1/2
  • Yale University (Data Collection Only), New Haven
Alder 18 og eldre · Menn · Oppdatert 25. jun. 2026 · NCT06457919

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

RekruttererObservasjonsstudie
  • Yale University, New Haven
Alder 21 og eldre · Menn · Oppdatert 22. mai 2026 · NCT03151629

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RekruttererFase 1/2
  • Yale University, Yale Cancer Center, New Haven
Alder 18 og eldre · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06395519

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

RekruttererFase 2
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • Yale University, New Haven
  • Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi unna
  • og 2 flere
Alder 18 og eldre · Menn · Oppdatert 29. jan. 2026 · NCT05806515

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RekruttererFase 3
  • Yale University, New Haven
  • Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3 mi unna
  • Smilow Cancer Hospital Care Center - Guilford, Guilford · 13 mi unna
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2025 · NCT03678025

Prostatakreft-studier i andre byer

Andre studier i New Haven

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.